<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QNA-C-CDF-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling up HIV prevention, care and treatment services for Key Populations and People living with HIV in Kosovo, and Strengthening Tuberculosis ("TB") control in Kosovo - Kosovo (01-Jan-2022-31-Dec-2024)</narrative>
    </title>
    <description type="1">
      <narrative>Kosovo, TB/HIV, Community Development Fund</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To maintain low prevalence of HIV among general population and key populations and improve the quality of life of people affected by AIDS in Kosovo; To reduce the overall incidence of notified cases from 33.8  per 100,000 in 2019 to 23.6  per 100,000 in 2024 and maintain tuberculosis mortality in Kosovo below 1.5/100,000. Objectives: Reduce the impact of HIV in general population and key populations by strengthening HIV prevention interventions and improve access to services; Improve the health status and quality of life of people living with HIV by providing universal access to treatment, health care and other support services; Ensure sustainable response to HIV through strengthening coordination, leadership and financial and political commitment of the Government; Ensure sustainable response to HIV through resilient health systems strengthening interventions; Empowerment and engagement of CSO in HIV policy, programming, advocacy and HIV services in the community through CSS; Successfully treat all cases of tuberculosis and maintain at least 85% the treatment success rate; Strengthen the early prevention and detection of tuberculosis by intensifying the active and passive findings of the cases by providing quality services and adequate measures of infection control and LTBI treatment of cases and other ongoing support; Establish and support national-level policies and legal framework and ensure greater government political and financial commitment to effective TB response in Kosovo; Improving patient-centred tuberculosis care through increased CSO engagement and strengthening public-private partnership; Improve national capacity to investigate and assess the impact of tuberculosis control and pre-elimination of interventions.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <other-identifier ref="QNA-C-CDFP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-01-01" />
    <activity-date type="2" iso-date="2022-01-01" />
    <activity-date type="3" iso-date="2024-12-31" />
    <activity-date type="4" iso-date="2024-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Olga Avdeeva</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>olga.avdeeva@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="XK" percentage="100">
      <narrative>Kosovo</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="48.71">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="37.29">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="14">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="23.66">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="2.99">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="d114003b-2059-4703-bbdf-e540a4be0418" percentage="1.79">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="3.08">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="1.84">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0d76926d-3ff4-4be9-b57c-a4cbfd9a134f" percentage="0.58">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="1f63d5bb-7cf1-4ecd-a1a0-6f951b7f88a7" percentage="0.58">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="2.63">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="32.87">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="0.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="1465be45-92ac-4824-ac40-65f735b3d8df" percentage="0.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="2.47">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7c509e7f-bfe6-4cf3-851a-a0a5a94b7401" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Civil registration and vital statistics</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="3.79">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="86ab2998-11d1-439b-a3b8-c56ee091314c" percentage="1.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; Policy and planning for national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="1b7258e5-95a1-4ad0-aa27-849d84eb27b3" percentage="0.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; In-service training (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="0fa82570-990a-4ca3-98f1-4952587f8be1" percentage="0.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="1a0e253d-91c8-4657-9773-7b54dc8e3409" percentage="3.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
        </description>
      </budget-item>
      <budget-item code="ca59d83d-94c4-4f56-93fe-88d1caf39c5a" percentage="0.38">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Infrastructure and equipment management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0.3">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="4.51">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="2.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="2.06">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="2.45">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="1.21">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.26">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1376877.86</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">2085361.55</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">1075269.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">289567.09</value>
    </budget>
    <capital-spend percentage="15.37" />
    <transaction ref="d6043adb-ceb9-4754-878a-807a97074e71">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-10" />
      <value currency="USD" value-date="2021-12-10">1799725.80</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ada03606-ac43-4c44-88de-3f575a2a4255">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-06" />
      <value currency="USD" value-date="2022-01-06">717868.69</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24043bf1-14c8-42e5-879e-c3890faa920c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-06" />
      <value currency="USD" value-date="2022-01-06">48907.19</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d2751200-8782-4d8a-94ae-7afe582e945a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-12" />
      <value currency="USD" value-date="2022-07-12">200353.25</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="356ace1f-538f-4009-b005-b5c97ba1c107">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-15" />
      <value currency="USD" value-date="2022-09-15">327786.67</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1ef7063b-183d-4563-97ed-ff41398ff346">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">8626.31</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04b304be-5be4-40a6-bc63-1a7da7ee6f50">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-16" />
      <value currency="USD" value-date="2022-11-16">119927.15</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5b3d86d6-d580-4f1a-8fa8-cdc26f71f01c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-17" />
      <value currency="USD" value-date="2023-01-17">566060.60</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d95a3bfc-3d50-44e0-9020-9673899ef2a8">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-01" />
      <value currency="USD" value-date="2023-03-01">269978.23</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a79d448-5816-4c9a-b24e-7f6c97dcf446">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-01" />
      <value currency="USD" value-date="2023-03-01">-80426.10</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3fd42b6e-1684-4dd9-a4e0-5df7d17891cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-16" />
      <value currency="USD" value-date="2023-03-16">58079.53</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e3766387-3b4b-4b8c-9974-71edd11f0e11">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-06" />
      <value currency="USD" value-date="2023-04-06">18791.46</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c258ebb-2fbc-4c19-9ed9-f7791947907d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-10" />
      <value currency="USD" value-date="2023-04-10">-211898.69</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33d2cda5-489d-445f-bfab-e20c555bec22">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-10" />
      <value currency="USD" value-date="2023-04-10">192156.47</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9fe08311-305a-4469-9ccd-de1224ac44ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-25" />
      <value currency="USD" value-date="2023-04-25">104895.66</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b56d4d25-2591-44b8-908c-e2d6c4e726f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-02" />
      <value currency="USD" value-date="2023-05-02">7228.89</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8136a18a-b1c8-4660-85e8-7953ce101b1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-01" />
      <value currency="USD" value-date="2023-06-01">8524.33</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d70e660a-b636-47e6-9c93-2d93a375cc97">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-29" />
      <value currency="USD" value-date="2023-06-29">5749.20</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="752c40c5-eaae-437a-8868-083b4e0481bd">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-04" />
      <value currency="USD" value-date="2023-08-04">-130476.36</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="121986fd-c5f7-4a7c-b3bd-9ee156d480b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-04" />
      <value currency="USD" value-date="2023-08-04">1404643.48</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0a666fa-eba1-4391-b803-0ffa9398c3c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-08" />
      <value currency="USD" value-date="2023-08-08">601428.34</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6dd2477f-fb9d-4fdf-8a54-3a950a57c632">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-08" />
      <value currency="USD" value-date="2023-08-08">138694.10</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1dbf086a-2682-435d-aa6b-3d7ae0132973">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-08" />
      <value currency="USD" value-date="2023-08-08">3060.24</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9added8d-bb2d-4394-9a3d-f9f1e9faf8ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-29" />
      <value currency="USD" value-date="2023-08-29">76866.24</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0491ab5f-e790-47f9-9610-b01e001a5c74">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-18" />
      <value currency="USD" value-date="2023-09-18">-7206.89</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cb1c3017-8eb9-4441-a104-9b26cc6647d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-30" />
      <value currency="USD" value-date="2023-09-30">30925.87</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fb88be41-f48e-4a3b-8dc2-e90cd117e86a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">151372.21</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6f0d64f7-f755-4581-b4dc-beeba155ec09">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">8275.51</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="28678527-82aa-4411-904f-7bed7f63c1aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-07" />
      <value currency="USD" value-date="2023-10-07">-10394.56</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6da69c35-4f67-46c3-a963-48237311df9f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-18" />
      <value currency="USD" value-date="2023-10-18">-5196.25</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="43a86c4c-eee8-4705-91aa-915f0839a595">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-18" />
      <value currency="USD" value-date="2023-10-18">15590.81</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f4a45a2e-1bf7-45cd-b831-c0124ecf3b1d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-19" />
      <value currency="USD" value-date="2023-10-19">-15590.81</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ddc513a-4ff3-475e-91c9-024669f947b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-11-12" />
      <value currency="USD" value-date="2023-11-12">-1479.69</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1de6af75-06a9-44b5-9192-89bc201fac67">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-30" />
      <value currency="USD" value-date="2024-01-30">6980.40</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5b70d322-135a-4328-b290-8547f710aa35">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-06" />
      <value currency="USD" value-date="2024-02-06">504873.32</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="baa7a8a2-6d67-4943-a9fc-f862d5e1b231">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-17" />
      <value currency="USD" value-date="2024-03-17">439399.99</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f61bd04a-5d72-4507-b5e6-5366ebd1740a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">439399.99</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="430fb9e1-5cf9-4bc0-8345-07aa6fcdbf65">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-24" />
      <value currency="USD" value-date="2024-05-24">143335.00</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6a0b87ec-c672-4332-988a-69550fbcd137">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-06" />
      <value currency="USD" value-date="2024-06-06">-23945.47</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="12f6732f-9ac3-4b6e-8658-fe615ab97d0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-06" />
      <value currency="USD" value-date="2024-06-06">9840.23</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04a9edc4-1ed6-481b-a9ec-42174fb471b7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-13" />
      <value currency="USD" value-date="2024-06-13">9840.23</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="89bcb212-48ff-4a57-b21d-e524dbe4df1e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">-143335.00</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="358d0844-e256-48eb-a330-be80ce4840c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">210619.13</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cc491324-022a-492f-9a95-6351911a65e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-13" />
      <value currency="USD" value-date="2024-07-13">13812.20</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1728645f-f855-4960-a7fb-77a579434853">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-26" />
      <value currency="USD" value-date="2024-07-26">272858.24</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7f54af57-2067-44d0-a039-b0730fd04cdf">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">-210619.13</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2013455e-5d64-4c96-9a68-464e318811c8">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-30" />
      <value currency="USD" value-date="2024-07-30">200178.94</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1c4d376e-8ba7-4afd-93ae-bbee09f49c1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">264048.88</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f5715bcc-eab6-4c66-89f2-bdfac650adda">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-24" />
      <value currency="USD" value-date="2024-08-24">-200178.94</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0ea8f2ed-1f63-4f37-8a4e-600be2ac331d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-24" />
      <value currency="USD" value-date="2024-08-24">526272.12</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5cf9e2c-bed8-4815-97f6-728feb4e2cab">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">17647.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-C-CDFP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="641ae473-b79d-4280-90fa-e8bdeaae93f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-23" />
      <value currency="USD" value-date="2024-09-23">-17647.38</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="23cc6ef1-51ab-4156-b96b-6d4333a8da4a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">27726.55</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c9fad804-71c2-48af-b96a-0ccb017fa78f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-24" />
      <value currency="USD" value-date="2024-09-24">98994.25</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e094d318-80a9-4964-8a06-2f9df312db45">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-26" />
      <value currency="USD" value-date="2024-09-26">6730.86</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af669a75-9b7e-4971-b8df-2ba47116907a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">7942.68</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9bc22ceb-1cdf-400f-8f4d-538eeaccce2d">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-11-13" />
      <value currency="USD" value-date="2024-11-13">8.77</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ec402085-9e21-40a8-a39f-24f13062df54">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-15" />
      <value currency="USD" value-date="2024-11-15">-8.77</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9bbae978-3119-469b-909e-e08f5ea6f2dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">28669.25</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="bbfac217-6215-463d-b4c3-cc3d73a53f5e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-21" />
      <value currency="USD" value-date="2024-11-21">44604.83</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="efc1444a-e142-4c21-8478-84583280e268">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-03" />
      <value currency="USD" value-date="2024-12-03">30859.58</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d94e9dce-43d2-4cac-9f2c-f4e22d923505">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-15" />
      <value currency="USD" value-date="2024-12-15">-295417.65</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="170e1998-6a72-4268-a5bd-3de9ad322ef8">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-15" />
      <value currency="USD" value-date="2024-12-15">289910.52</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c8c2c5c-1ac5-4f12-9243-c8ea72d26781">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">2954.23</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c76af2fe-c888-455d-a62a-2ce37e573af0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-23" />
      <value currency="USD" value-date="2025-01-23">272154.32</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e5988d19-54ac-4079-a906-c2a3eb5d421f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">9643.63</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="92d2fa56-ce23-4646-b28a-8e1a6950eb4f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-08" />
      <value currency="USD" value-date="2025-02-08">-17756.20</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3c1f8df-34ff-4519-907d-f87741a0cf8d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-16" />
      <value currency="USD" value-date="2025-03-16">-2915.29</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ee8e3cbf-7809-4a9d-8d33-16b614a70d2e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-04-23" />
      <value currency="USD" value-date="2025-04-23">-9643.63</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1af9aba0-70f5-48f4-bf75-20902653e8db">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-04-23" />
      <value currency="USD" value-date="2025-04-23">898.87</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3946c9e7-729a-487e-99ff-71fa57d8465c">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">64.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-C-CDFP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="36345934-8090-43e8-9fa7-eeb9cee1c39d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">-64.38</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2481c97e-fa62-4203-87ba-c9fe9bec59a8">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">6792.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-C-CDFP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1cef51d6-f395-4cbe-a96f-883151783fb5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-09" />
      <value currency="USD" value-date="2026-01-09">-6792.04</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="44eea6b5-4e71-4250-8aa4-6266b99190a3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-11" />
      <value currency="USD" value-date="2026-02-11">-2078.50</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ac8e2eb1-e1f0-4846-a504-6d7919db3b63">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">39087.85</value>
      <description>
        <narrative>Funds returned to the Global Fund from QNA-C-CDFP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c45ae734-0f03-47cb-a45f-2472bc21950c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">-39087.85</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="QNA-C-CDFP01-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">1054105.87</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-C-CDFP01, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-C-CDFP01-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">1504784.38</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-C-CDFP01, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-C-CDFP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">1875902.24</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-C-CDFP01, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QNA-C-CDFP01-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">275044.75</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-C-CDFP01, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QNA-C-CDF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/QNA/2020/TB_HIV/en/QNA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 3 - TB/HIV - Kosovo - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR856-QNA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-08-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="6.15">
          <comment>
            <narrative>Numerator: 419; Denominator: 6814.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="20.11">
            <comment>
              <narrative>Numerator: 1370; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="29.8">
            <comment>
              <narrative>Numerator: 2032; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="25.68">
            <comment>
              <narrative>Numerator: 1750; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="29.6">
            <comment>
              <narrative>Numerator: 2019; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="30.23">
            <comment>
              <narrative>Numerator: 2060; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="29.53">
            <comment>
              <narrative>Numerator: 2012; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="8.92">
          <comment>
            <narrative>Numerator: 519; Denominator: 5819.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="33.51">
            <comment>
              <narrative>Numerator: 1950; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="22.4">
            <comment>
              <narrative>Numerator: 1303; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="34.54">
            <comment>
              <narrative>Numerator: 2010; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="26.6">
            <comment>
              <narrative>Numerator: 1549; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="35.57">
            <comment>
              <narrative>Numerator: 2070; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="34.83">
            <comment>
              <narrative>Numerator: 2027; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="1.45">
          <comment>
            <narrative>Numerator: 73; Denominator: 5037.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="14.79">
            <comment>
              <narrative>Numerator: 745; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="13.3">
            <comment>
              <narrative>Numerator: 670; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="15.78">
            <comment>
              <narrative>Numerator: 795; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="16.4">
            <comment>
              <narrative>Numerator: 827; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16.78">
            <comment>
              <narrative>Numerator: 845; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="15.21">
            <comment>
              <narrative>Numerator: 766; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="66.67">
          <comment>
            <narrative>Numerator: 22; Denominator: 33.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="64.17">
            <comment>
              <narrative>Numerator: 77; Denominator: 120.</narrative>
            </comment>
          </target>
          <actual value="71.4">
            <comment>
              <narrative>Numerator: 10; Denominator: 14.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="75.2">
            <comment>
              <narrative>Numerator: 94; Denominator: 125.</narrative>
            </comment>
          </target>
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 9; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="83.08">
            <comment>
              <narrative>Numerator: 108; Denominator: 130.</narrative>
            </comment>
          </target>
          <actual value="62.99">
            <comment>
              <narrative>Numerator: 97; Denominator: 154.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="24.7">
          <comment>
            <narrative>Numerator: 1683; Denominator: 6814.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="38.16">
            <comment>
              <narrative>Numerator: 2600; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="38.4">
            <comment>
              <narrative>Numerator: 2615; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="44.03">
            <comment>
              <narrative>Numerator: 3000; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="38.9">
            <comment>
              <narrative>Numerator: 2652; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50.63">
            <comment>
              <narrative>Numerator: 3450; Denominator: 6814.</narrative>
            </comment>
          </target>
          <actual value="46.95">
            <comment>
              <narrative>Numerator: 3199; Denominator: 6814.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="26.07">
          <comment>
            <narrative>Numerator: 1517; Denominator: 5819.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="71.06">
            <comment>
              <narrative>Numerator: 4135; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="51.3">
            <comment>
              <narrative>Numerator: 2987; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="71.58">
            <comment>
              <narrative>Numerator: 4165; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="56.3">
            <comment>
              <narrative>Numerator: 3279; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="72.09">
            <comment>
              <narrative>Numerator: 4195; Denominator: 5819.</narrative>
            </comment>
          </target>
          <actual value="80.07">
            <comment>
              <narrative>Numerator: 4659; Denominator: 5819.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="4.61">
          <comment>
            <narrative>Numerator: 232; Denominator: 5037.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="18.07">
            <comment>
              <narrative>Numerator: 910; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="11.7">
            <comment>
              <narrative>Numerator: 589; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="19.06">
            <comment>
              <narrative>Numerator: 960; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="19.5">
            <comment>
              <narrative>Numerator: 982; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="20.05">
            <comment>
              <narrative>Numerator: 1010; Denominator: 5037.</narrative>
            </comment>
          </target>
          <actual value="20.17">
            <comment>
              <narrative>Numerator: 1016; Denominator: 5037.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="438" />
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="560" />
          <actual value="612" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="546" />
          <actual value="581" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="532" />
          <actual value="547" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="84.56">
          <comment>
            <narrative>Numerator: 515; Denominator: 609.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="86" />
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 381; Denominator: 446.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="87" />
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 530; Denominator: 601.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="88" />
          <actual value="85.79">
            <comment>
              <narrative>Numerator: 483; Denominator: 563.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="40.18">
          <comment>
            <narrative>Numerator: 176; Denominator: 438.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="70" />
          <actual value="63.2">
            <comment>
              <narrative>Numerator: 387; Denominator: 612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80" />
          <actual value="33.2">
            <comment>
              <narrative>Numerator: 193; Denominator: 581.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="47.71">
            <comment>
              <narrative>Numerator: 261; Denominator: 547.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="37.08">
          <comment>
            <narrative>Numerator: 33; Denominator: 89.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="52.08">
            <comment>
              <narrative>Numerator: 50; Denominator: 96.</narrative>
            </comment>
          </target>
          <actual value="51">
            <comment>
              <narrative>Numerator: 49; Denominator: 96.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="56.44">
            <comment>
              <narrative>Numerator: 57; Denominator: 101.</narrative>
            </comment>
          </target>
          <actual value="58.4">
            <comment>
              <narrative>Numerator: 59; Denominator: 101.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="61.32">
            <comment>
              <narrative>Numerator: 65; Denominator: 106.</narrative>
            </comment>
          </target>
          <actual value="88.68">
            <comment>
              <narrative>Numerator: 94; Denominator: 106.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QNA-C-CDF-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>TBC by the Country team - Kosovo (01-Jan-2025-31-Dec-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Kosovo, TB/HIV, Community Development Fund</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Promote transition readiness and full transition to government financing of all services including implemented by civil society; Assure continuation of evidence-based programs for key and vulnerable populations; Respond to human rights and gender-related barriers and vulnerabilities in access to services. Objectives: Implement capacity-building and legal framework developement activities tailored to the needs of civil society organizations to strengthen their ability to manage government funds, comply with regulatory requirements, and sustain service delivery; Establish mechanisms for collaboration and partnership between government agencies and civil society organizations to facilitate a smooth transition process, including joint planning, resource sharing, and knowledge exchange; Advocate for policy reforms and legislative changes to support the transition to government financing, including the development of funding mechanisms that prioritize sustainability, equity, and accountability; Identify and prioritize evidence-based programs that have demonstrated effectiveness in addressing the needs of key and vulnerable populations; Develop guidelines and standards for the implementation of evidence-based interventions; Allocate resources and funding to support the scale-up and expansion of evidence-based interventions with the greatest potential for impact and reach among key and vulnerable populations; Identify human rights and gender-related barriers and vulnerabilities in access to services, including discrimination, stigma, violence, and lack of legal protection; Develop and implement policies and strategies to address these barriers, including measures to promote equality, non-discrimination, and meaningful participation of KPs in decision-making processes; Provide training and capacity-building activities for service providers to enhance their understanding of human rights and gender issues and their ability to provide inclusive not-stigmatizing and non-discriminatory services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Community Development Fund</narrative>
    </participating-org>
    <other-identifier ref="QNA-C-CDFP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-01-01" />
    <activity-date type="2" iso-date="2025-01-01" />
    <activity-date type="3" iso-date="2027-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Olga Avdeeva</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>olga.avdeeva@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="XK" percentage="100">
      <narrative>Kosovo</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="50.31">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="36.56">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="13.13">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="9.1">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="1.57">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="1.35">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="2.05">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="1.61">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="2.38">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.85">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.19">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="7.05">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="d016d725-1006-44b1-8b50-da67f4621072" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="2.19">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="1.15">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="2.06">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.29">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.34">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="4.07">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="41.97">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9b9a3c4-223c-4954-a77c-8062d853f268" percentage="1.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Community-led advocacy and monitoring of domestic resource mobilization</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.5">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="69e672f0-6d26-46e7-8e97-fcb0b6526cb4" percentage="2.49">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; National health sector strategy, policy &amp; regulations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="2.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="1.69">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="9.4">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="3.74">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">936022.25</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">1031489.33</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">744315.61</value>
    </budget>
    <capital-spend percentage="5.62" />
    <transaction ref="b1792816-692c-4ffd-a236-caca95bb2630">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-24" />
      <value currency="USD" value-date="2025-01-24">1634380.15</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75543a3e-e9f2-42cf-b14d-92e10846b498">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">510238.74</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="56ac6df3-f145-4e12-86a5-95ec3c661c49">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-20" />
      <value currency="USD" value-date="2025-07-20">-1124141.41</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="989dd5b8-6a7a-4ee7-99dd-bf2f943736bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-20" />
      <value currency="USD" value-date="2025-07-20">448552.20</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="303764b9-caab-4f39-a34b-c243e3101414">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">425634.80</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cbfd6f5d-1cd7-4c72-9498-3fd29aceb204">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">16038.18</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6235b1fc-124a-406f-9e85-4ff64774ca67">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">6879.22</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a63246cc-1817-4171-9738-73c1102e3783">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">6118.23</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8d3b4bb0-2b08-4891-9b12-b60b65b44dc7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-09" />
      <value currency="USD" value-date="2026-01-09">6118.23</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="feeefcfa-7cc1-4a11-af92-3eabb3d02c82">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-02" />
      <value currency="USD" value-date="2026-02-02">306951.49</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d45eddc-899f-4cf2-8620-8ed765212d1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">306951.49</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0628a33d-29fe-4b47-a9fd-a974ff48509d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-01" />
      <value currency="USD" value-date="2026-05-01">863392.08</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fb34a37e-f287-429e-98c3-cd64e1935f8d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-12" />
      <value currency="USD" value-date="2026-05-12">424195.46</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af3866f4-2dbb-4078-8bc3-2d7a136c2d7d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">35210.13</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ba36b98-c712-49c8-9dde-24f6b6bd01cc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-21" />
      <value currency="USD" value-date="2026-05-21">35210.13</value>
      <description>
        <narrative>Global Fund commitment to QNA-C-CDFP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="64bd42d9-ebc9-4371-9e04-3cae99888707">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-05" />
      <value currency="USD" value-date="2026-10-05">267514.16</value>
      <description>
        <narrative>Global Fund disbursement to QNA-C-CDFP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Community Development Fund</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="QNA-C-CDFP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">897452.96</value>
      <description>
        <narrative>Expenditure reported by Community Development Fund for QNA-C-CDFP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Community Development Fund</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QNA-C-CDF" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/QNA/2024/TB_HIV/en/QNA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - TB/HIV - Kosovo - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1696-QNA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="2">
        <narrative>3 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="1">
        <narrative>4 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 636,020 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.4(1)(a) and 5.4(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the letter from the Republic of Kosovo dated 11 November 2024 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of EUR 9,425,743 from 2025-2027 (inclusive), comprising investments in: i. HIV of EUR 5,949,427 ii. TB of EUR 3,476,316 (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing Commitment Letter; and (c) provide to the Global Fund, by no later than 31 May of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV and TB for the upcoming year; and ii. the total expenditure for HIV and TB in the previous fiscal year.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="29.63">
          <comment>
            <narrative>Numerator: 2019; Denominator: 6814.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="68.25">
            <comment>
              <narrative>Numerator: 3300; Denominator: 4835.</narrative>
            </comment>
          </target>
          <actual value="72.6">
            <comment>
              <narrative>Numerator: 3510; Denominator: 4835.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="74.46">
            <comment>
              <narrative>Numerator: 3600; Denominator: 4835.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="80.66">
            <comment>
              <narrative>Numerator: 3900; Denominator: 4835.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="26.62">
          <comment>
            <narrative>Numerator: 1549; Denominator: 5819.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="59.91">
            <comment>
              <narrative>Numerator: 2300; Denominator: 3839.</narrative>
            </comment>
          </target>
          <actual value="55.04">
            <comment>
              <narrative>Numerator: 2113; Denominator: 3839.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="67.73">
            <comment>
              <narrative>Numerator: 2600; Denominator: 3839.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="75.54">
            <comment>
              <narrative>Numerator: 2900; Denominator: 3839.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="16.42">
          <comment>
            <narrative>Numerator: 827; Denominator: 5037.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="21.08">
            <comment>
              <narrative>Numerator: 900; Denominator: 4270.</narrative>
            </comment>
          </target>
          <actual value="19.6">
            <comment>
              <narrative>Numerator: 837; Denominator: 4270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="23.42">
            <comment>
              <narrative>Numerator: 1000; Denominator: 4270.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="35.13">
            <comment>
              <narrative>Numerator: 1500; Denominator: 4270.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-6 Other1  Number of KPs who received any PrEP product at least once during the reporting period.</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>KP-6 Other1  Number of KPs who received any PrEP product at least once during the reporting period.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 18.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 48; Denominator: 700; Percentage: 6.86%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 900.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1100.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="38.92">
          <comment>
            <narrative>Numerator: 2652; Denominator: 6814.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="74.46">
            <comment>
              <narrative>Numerator: 3600; Denominator: 4835.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 4274; Denominator: 4835.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80.66">
            <comment>
              <narrative>Numerator: 3900; Denominator: 4835.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="84.8">
            <comment>
              <narrative>Numerator: 4100; Denominator: 4835.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="56.35">
          <comment>
            <narrative>Numerator: 3279; Denominator: 5819.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85.96">
            <comment>
              <narrative>Numerator: 3300; Denominator: 3839.</narrative>
            </comment>
          </target>
          <actual value="102.84">
            <comment>
              <narrative>Numerator: 3948; Denominator: 3839.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="88.56">
            <comment>
              <narrative>Numerator: 3400; Denominator: 3839.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="91.17">
            <comment>
              <narrative>Numerator: 3500; Denominator: 3839.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="19.5">
          <comment>
            <narrative>Numerator: 982; Denominator: 5037.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="28.1">
            <comment>
              <narrative>Numerator: 1200; Denominator: 4270.</narrative>
            </comment>
          </target>
          <actual value="28.17">
            <comment>
              <narrative>Numerator: 1203; Denominator: 4270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="35.13">
            <comment>
              <narrative>Numerator: 1500; Denominator: 4270.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="42.15">
            <comment>
              <narrative>Numerator: 1800; Denominator: 4270.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="581" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="600" />
          <actual value="463" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="600" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="600" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="31.84">
          <comment>
            <narrative>Numerator: 185; Denominator: 581.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="35" />
          <actual value="39.09">
            <comment>
              <narrative>Numerator: 181; Denominator: 463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="48" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="60" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="88.19">
          <comment>
            <narrative>Numerator: 530; Denominator: 601.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="88.67">
            <comment>
              <narrative>Numerator: 532; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="85.42">
            <comment>
              <narrative>Numerator: 463; Denominator: 542.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="89.83">
            <comment>
              <narrative>Numerator: 539; Denominator: 600.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 548; Denominator: 600.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="84" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="82" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="110" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="58.42">
          <comment>
            <narrative>Numerator: 59; Denominator: 101.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="71.43">
            <comment>
              <narrative>Numerator: 90; Denominator: 126.</narrative>
            </comment>
          </target>
          <actual value="63.4">
            <comment>
              <narrative>Numerator: 123; Denominator: 194.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="84.62">
            <comment>
              <narrative>Numerator: 110; Denominator: 130.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-12-31" />
          <target value="94.74">
            <comment>
              <narrative>Numerator: 126; Denominator: 133.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>